Author: Barnes, Betsy J.; Adrover, Jose M.; Baxter-Stoltzfus, Amelia; Borczuk, Alain; Cools-Lartigue, Jonathan; Crawford, James M.; Daßler-Plenker, Juliane; Guerci, Philippe; Huynh, Caroline; Knight, Jason S.; Loda, Massimo; Looney, Mark R.; McAllister, Florencia; Rayes, Roni; Renaud, Stephane; Rousseau, Simon; Salvatore, Steven; Schwartz, Robert E.; Spicer, Jonathan D.; Yost, Christian C.; Weber, Andrew; Zuo, Yu; Egeblad, Mikala
Title: Targeting potential drivers of COVID-19: Neutrophil extracellular traps Cord-id: 37i62atc Document date: 2020_4_16
ID: 37i62atc
Snippet: Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10–15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered by a cytokine storm. In this Perspective, autopsy results and literature are presented supporting the hypothesis that a little known yet powerful function of neutrophils—the ability to form neutrophil extracellular traps (NETs)—may contribute to organ damage and mortality in COVID-19. We show lung infiltration of
Document: Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10–15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered by a cytokine storm. In this Perspective, autopsy results and literature are presented supporting the hypothesis that a little known yet powerful function of neutrophils—the ability to form neutrophil extracellular traps (NETs)—may contribute to organ damage and mortality in COVID-19. We show lung infiltration of neutrophils in an autopsy specimen from a patient who succumbed to COVID-19. We discuss prior reports linking aberrant NET formation to pulmonary diseases, thrombosis, mucous secretions in the airways, and cytokine production. If our hypothesis is correct, targeting NETs directly and/or indirectly with existing drugs may reduce the clinical severity of COVID-19.
Search related documents:
Co phrase search for related documents- aberrant immune response and lung infection: 1, 2
- aberrant immune response and lung injury: 1
- aberrant net formation and acute capillaritis: 1
- aberrant net formation and lung injury: 1
- aberrant net formation link and acute capillaritis: 1
- aberrant net formation link and lung injury: 1
- accelerated production and acute lung injury: 1
- accelerated production and lung function: 1
- accelerated production and lung infection: 1
- accelerated production and lung injury: 1
- active form and lung infection: 1, 2
- acute capillaritis and lung injury: 1, 2
- acute kidney cardiac injury and long duration: 1
- acute kidney cardiac injury and lung function: 1
- acute kidney cardiac injury and lung injury: 1, 2
- acute lung injury and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and lung injury animal model: 1, 2, 3, 4, 5
- acute lung injury and lung injury limit: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date